ABI
NPSP

Adamant Biomedical Investments’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Adamant Biomedical Investments’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.22M Hold
34,000
– – 0.29% 79
2014
Q3 		$884K Buy
+34,000
New +$977K 0.22% 79

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Adamant Biomedical Investments's NPSP Position: Q4 2014 in Review

Adamant Biomedical Investments held its NPS PHARMACEUTICALS INC (NPSP) position steady in Q4 2014 at 34,000 shares worth $1.22M. The position accounts for 0.29% of the portfolio, ranked #79.

Adamant Biomedical Investments first reported a position in NPSP in Q3 2014 and has held it in 2 quarters since. 213 funds tracked by Wall St. Rank hold NPSP as of Q4 2014.

  • Adamant Biomedical Investments held 34,000 shares of NPS PHARMACEUTICALS INC worth $1.22M as of Q4 2014.
  • Adamant Biomedical Investments left its NPS PHARMACEUTICALS INC share count unchanged in Q4 2014.
  • NPS PHARMACEUTICALS INC made up 0.29% of Adamant Biomedical Investments's portfolio in Q4 2014, its #79 holding.
  • Adamant Biomedical Investments first reported a position in NPS PHARMACEUTICALS INC in Q3 2014 and has held it in 2 quarters since.
  • 213 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.